£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

World Outlook for Non-Hodgkin Lymphoma Treatments 2025-2030

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 12 August 2026 02 September 2026 24 September 2026 15 October 2026 06 November 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £790 Days at Price

Price Analysis

Most common price: £790 (87 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 87 days

Description

Gain comprehensive market intelligence with The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments. This study provides a detailed analysis of the global landscape, covering more than 190 countries. By utilizing econometric models that project fundamental economic dynamics, the report offers precise estimates for latent demand, also known as potential industry earnings (P.I.E.), in millions of U.S. dollars for each reported year. Users can leverage comparative benchmarks to evaluate specific countries against regional and global market shares. This data allows for a quick assessment of market position and growth potential across various territories. It is an essential resource for understanding the economic trajectory and market distribution of Non-Hodgkin Lymphoma treatments on a global scale.

Key Features

Covers the world outlook for Non-Hodgkin Lymphoma treatments across more than 190 countries.

Provides estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes regional and global percent share data to allow for quick comparative benchmarking between countries.

Uses econometric models to project fundamental economic dynamics within and across different countries.

Delivers yearly reported estimates to track market trends from 2025 through 2030.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma
99% match

World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma

£790.00 07 Nov 2026
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report
99% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report

£520.00 13 Sep 2026
Non-Hodgkin's and Chronic Lymphoma Market Outlook in India
99% match

Non-Hodgkin's and Chronic Lymphoma Market Outlook in India

£515.00 08 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 07 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 25 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
98% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 07 Nov 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
98% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 26 Aug 2026
Lymphoma Treatment Outlook in India 2023-2028 Study
98% match

Lymphoma Treatment Outlook in India 2023-2028 Study

£515.00 06 Nov 2026
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study
98% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study

£490.00 25 Aug 2026
Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028
98% match

Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028

£490.00 28 Aug 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
98% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
98% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 07 Nov 2026
Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028
98% match

Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028

£490.00 28 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
98% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 06 Nov 2026
Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study
98% match

Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study

£325.00 03 Sep 2026
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
97% match

The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes

£490.00 28 Aug 2026
World Outlook for Immune-Oncology Treatments 2025-2030
97% match

World Outlook for Immune-Oncology Treatments 2025-2030

£790.00 25 Aug 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
2025-2030 World Outlook for Immuno Oncology Assays Report
97% match

2025-2030 World Outlook for Immuno Oncology Assays Report

£790.00 26 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026